---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-089966"
form_type: "8-K"
ticker: "REVB"
cik: "0001810560"
company_name: "REVELATION BIOSCIENCES, INC."
filed_at: "2024-08-02T23:59:59+00:00"
generated_at: "2026-05-31T13:29:45.425439+00:00"
event_type: "litigation"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Revelation Biosciences faces $7.3M judgment in LifeSci Capital lawsuit

## Summary
- U.S. District Court entered summary judgment against Revelation Biosciences for ~$7.3M in unpaid banking and advisory fees plus interest.
- Judgment adopted Magistrate Judge's December 2023 recommendation; company had contested fee obligation from pre-merger contracts.
- Company states it has sufficient cash to satisfy the judgment and expects no immediate impact on clinical trial programs.

## SEC filing metadata
- accession: 0000950170-24-089966
- form_type: 8-K
- ticker: REVB
- cik: 0001810560
- company_name: REVELATION BIOSCIENCES, INC.
- filed_at: 2024-08-02T23:59:59+00:00
- event_type: litigation
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1810560/000095017024089966/0000950170-24-089966-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1810560/000095017024089966/revb-20240801.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-089966
- JSON: https://secwatch.observer/filing/0000950170-24-089966.json
- Plain text: https://secwatch.observer/filing/0000950170-24-089966.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.